HeartBeam Announces FDA Submission of HeartBeam AIMIGo™ VECG System

HeartBeam, Inc. today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its HeartBeam AIMIGo™ System.

Scroll to Top